These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24926708)

  • 1. National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.
    Okam MM; Shaykevich S; Ebert BL; Zaslavsky AM; Ayanian JZ
    Med Care; 2014 Jul; 52(7):612-8. PubMed ID: 24926708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
    Kang HA; Barner JC
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448
    [No Abstract]   [Full Text] [Related]  

  • 3. Examining the effectiveness of hydroxyurea in people with sickle cell disease.
    Lanzkron S; Haywood C; Fagan PJ; Rand CS
    J Health Care Poor Underserved; 2010 Feb; 21(1):277-86. PubMed ID: 20173269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea therapy in children severely affected with sickle cell disease.
    Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
    J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children.
    Brousseau DC; Richardson T; Hall M; Ellison AM; Shah SS; Raphael JL; Bundy DG; Arnold S
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31227564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States.
    Oladipupo F; Stanek J; Walden J; Young J; Rose MJ; Nicol K; Villella A; Creary S
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30945. PubMed ID: 38462769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
    Akar NA; Adekile A
    Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.
    Ballas SK; Bauserman RL; McCarthy WF; Castro OL; Smith WR; Waclawiw MA;
    J Pain Symptom Manage; 2010 Dec; 40(6):870-82. PubMed ID: 20864308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five years of experience with hydroxyurea in children and young adults with sickle cell disease.
    Ferster A; Tahriri P; Vermylen C; Sturbois G; Corazza F; Fondu P; Devalck C; Dresse MF; Feremans W; Hunninck K; Toppet M; Philippet P; Van Geet C; Sariban E
    Blood; 2001 Jun; 97(11):3628-32. PubMed ID: 11369660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study.
    Shah N; Bhor M; Xie L; Halloway R; Arcona S; Paulose J; Yuce H
    Health Qual Life Outcomes; 2019 Oct; 17(1):155. PubMed ID: 31619251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea for the treatment of sickle cell disease.
    Segal JB; Strouse JJ; Beach MC; Haywood C; Witkop C; Park H; Wilson RF; Bass EB; Lanzkron S
    Evid Rep Technol Assess (Full Rep); 2008 Mar; (165):1-95. PubMed ID: 18457478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea Initiation Among Children With Sickle Cell Anemia.
    Reeves SL; Jary HK; Gondhi JP; Raphael JL; Lisabeth LD; Dombkowski KJ
    Clin Pediatr (Phila); 2019 Nov; 58(13):1394-1400. PubMed ID: 31113236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease.
    Darbari DS; Hampson JP; Ichesco E; Kadom N; Vezina G; Evangelou I; Clauw DJ; Taylor Vi JG; Harris RE
    J Pain; 2015 Nov; 16(11):1077-86. PubMed ID: 26291276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perception to hydroxyurea therapy in patients with sickle cell disease: Report from 3 centers.
    Korubo KI; Onodingene NM; Okoye HC; Omunakwe HE
    Ann Afr Med; 2021; 20(2):127-131. PubMed ID: 34213480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.
    Rigano P; De Franceschi L; Sainati L; Piga A; Piel FB; Cappellini MD; Fidone C; Masera N; Palazzi G; Gianesin B; Forni GL;
    Blood Cells Mol Dis; 2018 Mar; 69():82-89. PubMed ID: 29107441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia.
    Wang WC; Oyeku SO; Luo Z; Boulet SL; Miller ST; Casella JF; Fish B; Thompson BW; Grosse SD;
    Pediatrics; 2013 Oct; 132(4):677-83. PubMed ID: 23999955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.
    Lanzkron S; Haywood C; Segal JB; Dover GJ
    Am J Hematol; 2006 Dec; 81(12):927-32. PubMed ID: 16924648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.